top
Search terms
Results 11 - 20 of 21 - ordered by :
Pages: 1 2 3
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Ehjournal

The interface between recurrent thrombotic arterial events and the potential bleeding hazards of antithrombotic treatment after an acute coronary syndrome (ACS) occupies a central position in the ...

European Heart Journal, Armstrong, Paul W., Harrington, Robert A.

Date : 01/10/2012 Item size : 146454 bytes
Revistaespanola

Introduction Based on the current European guidelines,1, 2 stratification for thromboembolic risk in atrial fibrillation (AF) is largely based on clinical risk scoring systems, such as the CHADS2 ...

Revista Española de Cardiología

Date : 01/01/2013 Item size : 67834 bytes
Ehjournal

Antithrombotic strategies in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are evolving. Oral anticoagulation (OAC) has been shown to be superior to dual ...

European Heart Journal, Hammoudi, Nadjib, Montalescot, Gilles

Date : 14/05/2018 Item size : 126107 bytes
Revistaespanola

A weak, grade IIb recommendation (ie, usefulness/efficacy less well established by evidence/opinion) was released by the 2012 European atrial fibrillation guidelines, reflecting uncertainty over ...

Revista Española de Cardiología

Date : 01/02/2013 Item size : 53714 bytes
Revistaespanola

To the Editor, Triple antithrombotic therapy with aspirin, clopidogrel, and warfarin is used in about 5% of patients after coronary stent implantation, mostly due to atrial fibrillation and left ...

Revista Española de Cardiología

Date : 01/03/2014 Item size : 35435 bytes
Ehjournal

Antithrombotic strategies in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are evolving. Oral anticoagulation (OAC) has been shown to be superior to dual ...

European Heart Journal, Hammoudi, Nadjib, Montalescot, Gilles

Date : 14/05/2018 Item size : 133020 bytes
Ehjournal

For the prevention of the latter scenarios, anticoagulation has been introduced, initially with warfarin, a vitamin K antagonist, and more recently with novel oral anticoagulants or NOACs1 such as ...

European Heart Journal, Lüscher, Thomas F

Date : 14/05/2018 Item size : 4411 bytes
Ehjournal

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized ...

European Heart Journal, Golwala, Harsh B, Cannon, Christopher P, Steg, Ph Gabriel, Doros, Gheorghe, Qamar, Arman, Ellis, Stephen G, Oldgren, Jonas, ten Berg, Jurrien M, Kimura, Takeshi, Hohnloser, ...

Date : 14/05/2018 Item size : 4411 bytes
Escardio

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the ...

Date : 26/03/2019